Analysed NUWELLIS INC (NUWE:NASDAQ) News Sources
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders
24-06-2026
yahoo.com
Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations
25-06-2026
yahoo.com
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)
26-06-2026
yahoo.com
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
16-07-2026
yahoo.com
Nuwellis’ new CEO on building a strong foundation for sustainable value creation
27-07-2026
medicaldevice-network.com
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
27-07-2026
yahoo.com
Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin
28-07-2026
yahoo.com
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
30-07-2026
yahoo.com
What is the current price of NUWELLIS INC (NUWE:NASDAQ)?
The current price of NUWELLIS INC (NUWE:NASDAQ) is $1.74.
NUWELLIS INC (NUWE:NASDAQ) absolute price change since previous trading day?
The absolute price change of NUWELLIS INC (NUWE:NASDAQ) since the previous trading day is $-2.71.
NUWELLIS INC (NUWE:NASDAQ) percentage price change since previous trading day?
The percentage price change of NUWELLIS INC (NUWE:NASDAQ) since the previous trading day is -60.8989%.
What is the most recent average sentiment score for NUWELLIS INC (NUWE:NASDAQ)?
The most recent average sentiment score for NUWELLIS INC (NUWE:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for NUWELLIS INC (NUWE:NASDAQ)?
The most recent sentiment for NUWELLIS INC (NUWE:NASDAQ) is .
SEC-8K** Filing Available For NUWELLIS INC (NUWE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.